BlossomHill Therapeutics, Inc. Common Stock (BLSM) is a publicly traded the market company. As of November 3, 2026, BLSM trades at $12.39 with a market cap of $437.04M and a P/E ratio of 0.00. BLSM moved +0.00% today. Year to date, BLSM is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $12.37 to $27.99. Analyst consensus is strong buy with an average price target of $35.40. Rallies surfaces BLSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover BLSM: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $35.40.
| Metric | Value |
|---|---|
| Price | $12.39 |
| Market Cap | $437.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.99 |
| 52-Week Low | $12.37 |
| Volume | 838 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover BLSM: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.40.